Status:

RECRUITING

Electrostimulation Study for Ocular Graft vs. Host Disease

Lead Sponsor:

Zhonghui K. Luo, MD, PhD

Conditions:

Chronic Ocular Graft-versus-host Disease

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

This trial is testing to see if electrostimulation treatment (ET) will be effective in treating those with ocular Graft vs. Host Disease.

Detailed Description

The trial is to test whether transcutaneous electrical stimulation (TES) may be an effective new type of non-invasive treatment for patients who are diagnosed with chronic ocular Graft-vs-Host Disease...

Eligibility Criteria

Inclusion

  • Diagnosis of chronic ocular graft vs. host disease (oGVHD) (ICCGVHD criteria probable or definite)
  • OSDI score of 22 or higher
  • NEI corneal staining score (or modified NEI score) of 2 or higher.

Exclusion

  • Patients with any open wound on the eyelid.
  • Patient with any active cornea ulcer, dacryocystitis, hordeolum, filamentary keratitis, uveitis, retinal detachment, uncontrolled glaucoma or other active pathology per PI's discretion.
  • Patient with a pacemaker or ICD.
  • Patient currently pregnant or with a potential to be pregnant during the study.
  • Patient undergoing any ocular surgical procedure (including intravitreal injections) within the past 3 months.
  • Patient undergoing any systemic surgical procedures within 2 months.
  • Patient undergoing any non-surgical eyelid procedure such as punctal plugs or punctal cautery within 1 month of study initiation.
  • Patients on cytotoxic agents, drugs that inhibit peripheral nerve regeneration (i.e. Gabapentin, Nicotine), radiation therapy, or any other therapy per PI's discretion.
  • Patients undergoing immunosuppression regimen change within 1 month of study initiation and/or during the study period.
  • Patient who wears contact lens of any kind

Key Trial Info

Start Date :

November 30 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 30 2029

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT07166848

Start Date

November 30 2025

End Date

November 30 2029

Last Update

December 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Massachusetts Eye and Ear - Longwood Campus

Boston, Massachusetts, United States, 02215